Tuesday, April 24, 2018
 
 
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
American College of Medical Toxicology Members Working with Federal Agencies to Investigate Bleeding Complications from Synthetic Cannabinoid Use
 
(April 16, 2018)
American College of Medical Toxicology Members Working with Federal Agencies to Investigate Bleeding Complications from Synthetic Cannabinoid Use

Members of the American College of Medical Toxicology (ACMT) have been working with public health officials to investigate an outbreak of major bleeding complications associated with synthetic cannabinoid use this past month. Over 114 cases have been reported to the Illinois Department of Public Health (IDPH) as of April 10, 2018.

Information remains limited at this time, but affected patients report obtaining synthetic cannabinoids from friends, dealers, or convenience stores in various locations. The case rates in Peoria and Tazewell county are much higher than other areas of the state. Brodifacoum has been detected in the blood of several of patients.

Brodifacoum is a long acting anticoagulant or blood thinner. It is commonly found in rat and mouse poison, and its main effect is to deplete stores of vitamin K. Vitamin K is necessary to stop bleeding, and thus patients exposed to brodifacoum may develop serious bleeding complications. The effects of brodifacoum are prolonged, and may last weeks to months after the initial exposure. The treatment often requires vitamin K for several weeks to months, hospitalization, transfusion of various blood products, and close outpatient follow-up for monitoring of coagulation status.



Members of ACMT, Illinois Dept. of Public Health (IDPH), Center for Disease Control and Prevention (CDC), Illinois Poison Center (IPC), and local and federal law enforcement agencies are collaborating to investigate this outbreak. Several individuals have been arrested, but it remains unclear why or how brodifacoum and other related contaminants were added to synthetic cannabinoid products. Bleeding complications are not usually reported after synthetic cannabinoid use. Patients who believe they have been exposed are being asked to seek medical attention immediately.

ACMT-Advancing the Toxicological Care of Poisoned Patients and Populations
The American College of Medical Toxicology is a professional, nonprofit association of more than 700 physicians with recognized expertise in medical toxicology. Medical toxicology focuses on the diagnosis, management, and prevention of poisoning/toxicity and other adverse health effects resulting from medications, chemicals, occupational and environmental substances and biological hazards.

Read the full story at http://www.prweb.com/releases/2018/04/prweb15412447.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Centene Corporation Reports 2018 First Quarter Results And Adjusts 2018 Guidance
  • Pain Management Device Market Factor Analysis 2018 - Technological and Product Development to Drive the Global Industry by 2023
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases
  • Orthodontic Supplies Market to Hit 8.9% CAGR to 2023, Led by Align Technology, Inc. (US), 3M Company (US), and Danaher Corporation (US)
  • New Orleans' GAINSWave Offers GAINSWaveŽ in Louisiana

    Cancer
  • MOLOGEN AG: Announcement of the new dates for the publication of the Annual Financial Statements 2017 and the 2018 Annual General Meeting
  • Diagnosis (DX) Share Life - Life Just Got Personal
  • Mary Washington Healthcare Adopts Medpricer's Purchased Services Solutions
  • Mercy Health Standardizes Clinical Communication at 23 Provider Facilities with PerfectServe
  • Eceptionist Scheduling Software For Cellular Therapy - Project Implementation Abstract To Be Presented At The Annual ISCT Conference In Montreal
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines